These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26384512)

  • 1. Imaging of neuroinflammation in dementia: a review.
    Stefaniak J; O'Brien J
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):21-8. PubMed ID: 26384512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia.
    Kreisl WC; Henter ID; Innis RB
    Adv Pharmacol; 2018; 82():163-185. PubMed ID: 29413519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of dementia.
    Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T
    Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Fan Z; Okello AA; Brooks DJ; Edison P
    Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment.
    Knezevic D; Mizrahi R
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt B):123-131. PubMed ID: 28533150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging.
    Zhang J
    J Neuroinflammation; 2015 May; 12():108. PubMed ID: 26022249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET imaging of brain amyloid in dementia: a review.
    Quigley H; Colloby SJ; O'Brien JT
    Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging neuroinflammation in Alzheimer's disease and other dementias: Recent advances and future directions.
    Varley J; Brooks DJ; Edison P
    Alzheimers Dement; 2015 Sep; 11(9):1110-20. PubMed ID: 25449529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of positron emission tomography imaging in understanding Alzheimer's disease.
    Barthel H; Seibyl J; Sabri O
    Expert Rev Neurother; 2015 Apr; 15(4):395-406. PubMed ID: 25752209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
    Chiotis K; Saint-Aubert L; Savitcheva I; Jelic V; Andersen P; Jonasson M; Eriksson J; Lubberink M; Almkvist O; Wall A; Antoni G; Nordberg A
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1686-99. PubMed ID: 26996778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia.
    Stefani A; Sancesario G; Pierantozzi M; Leone G; Galati S; Hainsworth AH; Diomedi M
    J Neurol Sci; 2009 Aug; 283(1-2):109-15. PubMed ID: 19278690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
    Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
    Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.
    Thal DR; Attems J; Ewers M
    J Alzheimers Dis; 2014; 42 Suppl 4():S421-9. PubMed ID: 25227313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
    Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M;
    Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers.
    Anthony IC; Norrby KE; Dingwall T; Carnie FW; Millar T; Arango JC; Robertson R; Bell JE
    Brain; 2010 Dec; 133(Pt 12):3685-98. PubMed ID: 21126996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo molecular imaging of neuroinflammation in Alzheimer's disease.
    Chaney A; Williams SR; Boutin H
    J Neurochem; 2019 May; 149(4):438-451. PubMed ID: 30339715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
    Atri A
    Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.